ALIKO Scientific is a next-generation cancer diagnostics company operating at the forefront of immuno-oncology and laboratory automation. The company offers a fully integrated diagnostic platform combining Liquid Based Cytology (LBC) and Fluorescence In Situ Hybridization (FISH) technologies. Listed on Euronext Growth Paris, ALIKO Scientific serves clients across the Life Sciences sector with active operations in France, Italy, and the United States.